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We would like to applaud the authors of the article “The worldwide epidemiology of 
acute rheumatic fever (ARF) and rheumatic heart disease (RHD)”1 for highlighting 
this important disease which continues needlessly to kill people living in poverty while 
being largely ignored by the developed world.2 We would however like to address 
some key issues.
The authors state that: the evidence of serologic infection is based on one of   
“a pharyngeal swab culture positive for GABHS, positive rapid GABHS antigen test 
or rising serologic antibody titers”. Very few countries in highly affected regions of the 
world utilize routine rapid antigen or microbiological testing due to the cost involved. 
Furthermore, the delay involved in repeat serological testing before a diagnosis can 
be made, will result in missed diagnoses and tragic consequences. We recommend 
therefore that elevated serological markers of previous GABHS infection, together 
with major and minor criteria, are sufficient for a diagnosis of ARF.
Another contentious issue is echocardiography and the diagnosis of ARF. Although 
the American Heart Association guidelines do not recommend that evidence of 
subclinical regurgitation be used as a major or minor criterion, readers should be cog-
nizant of recommendations by the Heart Foundations of Australia and New Zealand 
developed in response to an extremely high prevalence of RHD in their indigenous 
populations.3 Admittedly, the use of echocardiography as a major criterion for ARF 
diagnosis does require expert interpretation, but is strongly considered by experts 
in affected regions to be pivotal in making this diagnosis, while also increasing the 
sensitivity of the Jones criteria.4
The third controversy stems from the treatment of GAS pharyngitis. Evidence for 
recommending oral penicillin as first line treatment is scant. Given that the few trials 
testing the efficacy of penicillin for preventing ARF were confined to intramuscular 
(as opposed to oral) penicillin,5,6 our recommendation is that intramuscular penicillin 
should be the first choice in keeping with the evidence. This will also result in better 
concordance.7
A final point relates to the use of aspirin. Aspirin is, indeed, particularly effective 
at rapidly resolving joint manifestations of ARF – so much so, that in areas of high 
endemicity, indiscriminate use of aspirin without due consideration of the diagnosis 
of ARF could lead to dramatic underestimation of the incidence of ARF.8 It is crucial 
therefore, to highlight the importance, in high-prevalence areas, of careful consideration 
of the diagnosis of ARF in any child presenting with arthritis,9 and to treat patients Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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with paracetomol rather than aspirin or nonsteroidals until a 
definitive diagnosis is made.
In conclusion, we suggest that this review would have 
been greatly improved by a more robust systematic review 
design, incorporating other databases, as well as foreign lan-
guage and unpublished data, in the search.10 As it stands, we 
believe that this review is most likely to have underestimated 
the problem of RHD, particularly in low- and middle-income 
countries. Given the availability of cheap and effective pre-
vention, the time has definitely come to accelerate efforts to 
control this disease.11
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First, we would like to thank the editors of Clinical 
Epidemiology for inviting this review of the published 
literature.1 In addition, we would like to thank Zühlke and 
colleagues for their thoughtful comments. We offer a few 
points for consideration.
We agree with the use of an elevated serologic antibody 
titer on initial presentation as an indication of recent strep-
tococcal infection, and support this for the clinical diagnosis 
of acute rheumatic fever.
While we presented the guidelines from the American 
Heart Association regarding the diagnostic criteria for acute 
rheumatic fever, we readily acknowledge variation in practice 
in other parts of the world.
As discussed and referenced in our review, the diagnostic 
use and utility of echocardiography in this disease is indeed 
controversial.1
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Regarding the use of intramuscular penicillin as a 
first-line treatment for pharyngitis, the increased cost and 
associated pain from an intramuscular injection must be 
balanced against the risk of incomplete treatment for acute 
pharyngitis. We recommend that clinicians adhere to local 
standards when determining the appropriate treatment course 
for their patients.
As referenced, this manuscript represents a review of 
publications from 100 countries, written in 9 languages. 
The study design, populations, definitions, and treatment 
options varied widely across time and between venues. While 
an attempt was made to maximize the contribution of each 
article, the limitations of meta-analysis in this setting were 
formidable. We recognize that the published literature to date 
describes a gross underestimate of the impact of this horrible 
disease, and applaud the editors of Clinical Epidemiology for 
seeking to shine a light on this heart of darkness.
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